. . . . . . . . . . . . "[The CYP1A1*2B allele may predispose to the development of these sub-groups of AML by augmented phase 1 metabolism to highly reactive intermediates of CYP1A1 substrates including polycyclic aromatic hydrocarbons or by generation of oxidative stress as a me]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2015-02-21"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2016-05-13T12:42:23+02:00"^^ . . . . . . . . . . . "v4.0.0.0" . "v4.0.0" .